Member Info for Fruitsnveg

"It wouldn't make sense for a non-BP to think they know better than BP as to the risk at this stage".

Given that many non-BP collaborators are ex-pharma people, that statement is wholly incorrect.

It's perfectly feasible that a non-BP collaborator could step in to partner on trials and provide funding. My view hasn't changed. Calling it a "punt" is juvenile. It would be a mutually beneficial arrangement based on very in-depth DD, such that it becomes feasibly de-risked to hit a sweet spot for a collaborator. Nothing at all outlandish about it.

I think there is greater chance of you waking up one day as the Christmas Fairy, than there is of TFG buying out the company to become a small scale Biotech company. Can you see Reade Griffith moving to Southampton Business Park with his clipboards and petri dishes? Nope. Me neither.

"I said before that unless a pharma wanted it, TFG would be the only candidate to offer the additional £35-£50m to make good on its original holding."

Lol.

"It's 8 weeks today since the AGM."

RNS tomo then Doc...?

Isn't mid-December the end the 8 weeks?

Ho ho ho

Neither.

No.

I still believe in Santa.

"SNG have to accept anything they can get at this stage!"

Another completely baloney sandwich. Must be a 2 for 1 offer this week.....

" The SP has been ground down into a penny share, yet no apology, no humility. "

What a baloney sandwich. Time to shut the front door on the negative BS. If you don't like the direction of travel, kindly pull the cord and alight. Simple.

No surprise that you mis-interpreted it Mani. Potential risk, not current issue. I think I made that pretty clear.

Obviously not clear enough for your Elon Musk Toddler energy today....

I think we shouldn't discount the possibility that US political headwinds could be having some impact. We know we have some form of tie up with the US on this next trial (as reported by posters here and elsewhere). That makes us dependent on FDA involvement to some degree. Although such a dependency may have zero impact, it could also slow down the US Regulator, or any US collaborating parties on our pathway to eventual approval of SNG001. RFK, Trump's pick for HHS, the NIH’s parent agency, said in 2023 that he would "seek an eight-year pause for infectious-diseases research at the NIH so that the biomedical funder can instead focus on chronic diseases such as diabetes and obesity. He also said on 9 November that he would seek to replace 600 employees at the NIH". Still to be seen if that materialises, but one to watch imho.

TP,

Did the CFO happen to speak at all at he AGM?

Thank you for confirming WiltsInvestor.

If you're going to make a non-risky decision to actively exercise your options, you could do worse than doing it on budget announcement day.

I would find it hard to view this negatively.

Spacemen,

You misunderstand. "They" meaning UK Life Sciences (researchers). They tend to work collaboratively. I'm not talking about data. Companies like Synairgen do not operate in a vacuum, I'm confident that new techniques / processes / technology / whatever novel methods that are coming online, which will increase our chances of success, will be embedded in our trial if / when they are available.

As for losing 98% of your investment, I'd have to assume you've sold out in order to affect a loss. Which begs the question why you're he posting if you sold out? Or, perhaps what you mean is your investment is down' 98%?

I remain invested, so I've lost nothing.

Any thoughts pmjh on how the UK - US side of the MVP trial could hang together? I don't think trial locations or numbers of centres or any real trial details were discussed at the AGM, but it would be interesting to hear peoples thoughts on that. And whether other locations (Europe, Asia) are likely to figure?

Yes, there will be a test to identify patients the MVP group, but it will be based on much more recent technology, it won't be your bog standard 2020 viral clearance test, IMHO.

OK. I'll clarify by saying I have zero doubt that this will be proved wrong, when the details of the trial become known...

"The only assay they plan to use in MV is the one which will measure viral clearance. All the bunkum about modern diagnostic tools has come to nothing for now "

I have zero doubt that this will be proved wrong, in due course.